Top Story

Systemic therapy underutilized in NSCLC treatment, particularly among older patients

May 28, 2015

Most patients with metastatic non–small cell lung cancer in the general population did not receive systemic therapy, especially if they were older or had squamous histology, according to the results of a retrospective analysis.

Patients who did receive first- and second-line systemic treatment demonstrated outcomes comparable to those achieved on clinical trials, the researchers also found.

Robert H.I. Andtbacka, MD In the JournalsPerspective

Higher response rate seen with T-VEC in advanced melanoma

May 28, 2015
Patients with unresected stage IIIB to IV melanoma who were treated with talimogene laherparepvec experienced a higher durable response rate than patients treated with…
In the Journals

Pharmacist-managed medication refill clinics ease physician workload

May 28, 2015
Establishing a pharmacist-managed medication refill clinic decreased workloads for physicians, and improved refill-request processing time and patient care, according to…
In the Journals

Serial biomarker levels may better detect epithelial ovarian cancer

May 28, 2015
Monitoring changes in annual serum cancer antigen 125 levels could detect twice the number of women with invasive epithelial ovarian cancer compared with standard…
In the Journals

Paternal age at birth, sibling status linked to blood cancer risk

May 28, 2015
Children without siblings and who were born to older fathers demonstrated an increased risk for developing hematologic malignancies in adulthood, according to the…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
morganatic-roan
morganatic-roan